BioVie Inc. Warrants (BIVIW) Live Share Price, Invest From India

BioVie Inc. Warrants Stock Performance

as on June 27, 2026 at 4:13 am IST

$0.43
Day's Price Range
$0.43
$0.43
52 Week's Low
52 Week's High
$0.17
52-Week Price Range
$0.52
$0.43
61.63%
Downside
20.93%
Upside

BioVie Inc. Warrants share price movements today

Previous Close: $0.39
Open: $0.43
Volume: 100.0
Day's Low - High: $0.43 - $0.43
52 Week Low - High: $0.17 - $0.52

BioVie Inc. Warrants Historical Returns

1 Month Return: + 25.81 %
3 Month Return: + 67.38 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

BioVie Inc. Warrants Stock Fundamentals & Key Indicators

Check BioVie Inc. Warrants market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-106.43%

BioVie Inc. Warrants vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioVie Inc. Warrants with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
BioVie Inc. Warrants	NA	$-	NA	NA	0.00%	NA
Insmed Inc.	BUY	$22.6B	260.99%	NA	-144.44%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.3B	67.15%	74.07	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.6B	147.08%	28.17	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	12.64%	15.22	29.65%	0.58%

Indian Investors' Interest in BioVie Inc. Warrants Stock

Search interest for BioVie Inc. Warrants Stock has increased by 260% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 29, 2026 to June 28, 2026

Change:260% versus previous 30 day period

BioVie Inc. Warrants Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-
Operating Income	-7	-4	-4	-7	-2	-3	-5	-6	-5
EBITDA	-	-	-	-	-	-	-	-	-
Interest Expense	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-4	-4	-7	-2	-3	-5	-6	-5
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-8	-4	-4	-7	-2	-3	-5	-6	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

BioVie Inc. Warrants Annual Profit & Loss

All numbers in Millions USD

	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
Operating Income	-7	-27	-45	-32	-18
EBITDA	-	-	-	-	-
Interest Expense	0	2	4	2	0
Depreciation	0	0	0	0	0
Income Before Tax	-130	-26	-50	-32	-17
Income Tax Expense	-	-	-	-	-
Net Income	-130	-26	-50	-32	-17
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

BioVie Inc. Warrants Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-8	-4	-4	-7	-2	-3	-5	-6	-5
Operating Cash Flow	-5	-4	-3	-8	-1	-5	-3	-4	-7
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	15	-2	0	12	-	-	10	-	-
Change in Cash	10	-6	-3	4	-1	-5	7	-4	-7

BioVie Inc. Warrants Annual Cash Flow

All numbers in Millions USD

	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-26	-50	-33	-17
Operating Cash Flow	-18	-40	-27	-19
Investing Cash Flow	-	-	-	-
Financing Cash Flow	33	55	17	12
Change in Cash	14	0	4	-6

Insights on BioVie Inc. Warrants

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, BIVIW stock has moved down by -16.7%

About BioVie Inc. Warrants

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

Organisation	BioVie Inc. Warrants
Headquarters	680 W. Nye Lane, Carson City, NV, United States, 89703
Industry	Miscellaneous
CEO	Mr. Cuong Viet Do M.B.A.
E-voting on shares	Click here to vote

Key Management of BioVie Inc. Warrants

Name	Title
Mr. David Morse	Senior VP & Chief Regulatory Officer
Mr. Cuong Viet Do M.B.A.	President, CEO & Director
Ms. Joanne Wendy Kim CPA	CFO, Treasurer & Corporate Secretary
Dr. Joseph M. Palumbo M.D.	Executive VP of R&D and Chief Medical Officer
Mr. Clarence N. Ahlem	Senior Vice President of Operations
Dr. Penelope Markham Ph.D.	Senior Vice President of Liver Disease Program
Ms. Denise Smith	Senior Vice President of Manufacturing & Development
Dr. Christopher L. Reading Ph.D.	Senior Vice President of Alzheimer's Disease Program

FAQs

What is BioVie Inc. Warrants share price today?

BioVie Inc. Warrants share price today is $0.43 as on June 26, 2026 at 10:43 pm IST at the close of the market. BioVie Inc. Warrants share today touched a day high of $0.43 and a low of $0.43.

What is the 52 week high and 52 week low for BioVie Inc. Warrants share?

BioVie Inc. Warrants share touched a 52 week high of $0.52 on September 12, 2025 and a 52 week low of $0.17 on April 7, 2026. BioVie Inc. Warrants stock price today i.e. June 26, 2026 at 10:43 pm IST is closed at $0.43,which is 17.31% down from its 52 week high and 160.61% up from its 52 week low.

How to invest in BioVie Inc. Warrants Stock (BIVIW) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for BioVie Inc. Warrants on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BioVie Inc. Warrants Shares that will get you 3.4884 shares as per BioVie Inc. Warrants share price of $0.43 per share as on June 26, 2026 at 10:43 pm IST.

What is the minimum amount required to buy BioVie Inc. Warrants Stock (BIVIW) from India?

Indian investors can start investing in BioVie Inc. Warrants (BIVIW) shares with as little as ₹94.3 or $1 (as of June 28, 2026 at 1:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in BioVie Inc. Warrants stock (as per the Rupee-Dollar exchange rate as on June 28, 2026 at 1:40 am IST). Based on BioVie Inc. Warrants share’s latest price of $0.43 as on June 26, 2026 at 10:43 pm IST, you will get 23.2558 shares of BioVie Inc. Warrants. Learn more about fractional shares .